The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response

MLA

Daniele Runci, et al. “The Clinical Value of Patient-Derived Glioblastoma Tumorspheres in Predicting Treatment Response.” Neuro-Oncology, vol. 19, Feb. 2017, pp. 1097–108. EBSCOhost, https://doi.org/10.1093/neuonc/now304.

APA

Daniele Runci, Alessandro Olivi, Ruggero De Maria, Luigi Maria Larocca, Tonia Cenci, Roberto Pallini, Mariachiara Buccarelli, Michele Signore, Lucia Ricci-Vitiani, Maurizio Martini, Quintino Giorgio D’Alessandris, Mauro Biffoni, & Louis Stancato. (2017). The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response. Neuro-Oncology, 19, 1097–1108. https://doi.org/10.1093/neuonc/now304

Chicago

Daniele Runci, Alessandro Olivi, Ruggero De Maria, Luigi Maria Larocca, Tonia Cenci, Roberto Pallini, Mariachiara Buccarelli, et al. 2017. “The Clinical Value of Patient-Derived Glioblastoma Tumorspheres in Predicting Treatment Response.” Neuro-Oncology 19 (February): 1097–1108. doi:10.1093/neuonc/now304.